Keyword: Biotechnology

News

Wacker Buys Dutch Biotechnology Plant

20.04.2018 - With the takeover of SynCo Bio Partners of Amsterdam from SynCo Bio Luxembourg, Germany’s Wacker Chemie has acquired a Dutch manufacturing site for biopharmaceuticals, live...

Strategy & Management

Hard Times for Bio-based Products

03.04.2018 - Petroleum is a limited resource and if we keep using it global warming will accelerate. Since this realization has filtered in the quest for alternatives has begun. Shale gas and...

Strategy & Management

Biotechnology Is about to Change Our Lives

30.03.2018 - Biotechnology encompasses a broad range of technologies that employ living organisms or parts of them to make diverse products. For example, drugs and therapeutics, nutritional...

News

David Estapé to Join CRB Group as Technology Manager Biotechnology

17.03.2018 - David Estapé, a long-time biotechnology expert who holds a doctorate in chemical engineering and has 22 years of experience, will join CRB Group as Technology Manager Biotechnology...

Plant Construction & Process Technology

Sartorius Stedim Biotech Supports ABL Europe in Viral Vector GMP Capacity Expansion

16.03.2018 - ABL Europe has successfully increased and brought online new viral vector manufacturing capacity at its European facility in Strasbourg. A subsidiary of ABL Inc., ABL Europe has...

Strategy & Management

Lonza Adds More Building Blocks for the Healthcare Continuum

27.02.2018 - Contract development and manufacturing organization (CDMO) Lonza said it exceeded its full-year 2017 guidance. The company reported sales of CHF 5.1 billion. Having closed the...

News

Azelis and Tagra Biotechnologies Extend Partnership

29.01.2018 - Israel’s Tagra Biotechnologies has appointed Azelis as the exclusive distributor of its range of Release on Demand (RND) microcapsules for all personal care applications in France...

News

Sanofi to Buy Hemophilia Specialist Bioverativ

24.01.2018 - Sanofi is boosting its presence in blood disorders through the acquisition of Bioverativ, the former hemophilia business of major US biotech Biogen, which was spun out in February...